Internal medicine

Pathology

Adverse effect

Clinical endpoint

Placebo

Colchicine

Myocardial infarction

Gastroenterology

Interquartile range

Surgery

Randomized controlled trial

Alternative medicine

Inflammation

Tolerability

C-reactive protein

Medicine

American Heart Journal

Following an acute myocardial infarction (MI), patients with persistently elevated biomarkers of inflammation, in particular C-reactive protein (CRP),…

The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction